Table 3.
Impact of inflammatory marker on overall response rate and disease‐control rate
| Inflammatory marker | Overall response | Disease control | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N = 84 | (%) | CR/PR | SD/PD | P‐value a | ORR (%) | (95% CI) | CR/PR/SD | PD | P‐value a | DCR (%) | (95% CI) | |
| NLR | ||||||||||||
| Low | 56 | (68) | 10 | 46 | 17.8 | (7.5‐28.2) | 32 | 24 | 57.1 | (43.8‐70.5) | ||
| High | 28 | (32) | 3 | 25 | 10.7 | (1.4‐22.9) | 7 | 21 | 25.0 | (7.9‐42.1) | ||
| .414 | .002 | |||||||||||
| mGPS | ||||||||||||
| 0/1 | 63 | (35) | 10 | 53 | 15.9 | (6.5‐25.1) | 33 | 30 | 52.3 | (39.7‐65.0) | ||
| 2 | 21 | (25) | 3 | 18 | 14.3 | (2.0‐30.6) | 6 | 15 | 28.6 | (7.5‐49.6) | ||
| .922 | .038 | |||||||||||
Abbreviations: DCR, disease control rate; mGPS, modified Glasgow Prognostic Score; NLR, neutrophil/lymphocyte ratio; ORR, overall response rate.
a
Cochran‐Mantel‐Haenszel test stratified by age, sex, and previous Cmab use.